Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/15/25 16:09 | 4/11/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Srinivasan Venkatesh | CA | O | Chief Te | 2 | M.d | 0 | 0.00 | 0 | 33 | 168 | 52 | D | ||||||||||||||
3/7/25 16:14 | 3/5/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Newell William J | CA | DO | CEO | 3 | M.d | 0 | 0.00 | 0 | 115 | 39 | 409 | D | ||||||||||||||
3/7/25 16:12 | 3/5/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Fitzpatrick Linda A | CA | O | Chief Pe | 3 | M.d | 0 | 0.00 | 0 | 38 | 56 | 106 | D | ||||||||||||||
3/7/25 16:11 | 3/5/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Albini Edward C | CA | O | CFO,Secr | 3 | M.d | 0 | 0.00 | 0 | 43 | 48 | 132 | D | ||||||||||||||
3/6/25 16:06 | 3/4/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Chung Jane | CA | O | P,COO | 2 | M.d | 0 | 0.00 | 0 | 40 | 68 | 98 | D | ||||||||||||||
3/4/25 18:34 | 3/1/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Gerber Hans-Peter | CA | O | CHIEF SC | 1 | M.d | 0 | 0.00 | 0 | 11 | 58 | 31 | D | ||||||||||||||
3/4/25 17:57 | 2/28/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Borgman Anne Elizabeth | CA | O | Chief Me | 1 | M.dm | 0 | 0.00 | 0 | 49 | 999% | 53 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |